Photo

Photo detail

Stories this photo appears in:

Zogenix Getting a Heaping Dose of Criticism for Zohydro

PHARMA: Stock Takes Hit, But Co. Defends Painkiller

Zogenix Inc. is in damage control mode as it faces a maelstrom of criticism for its newly launched narcotic painkiller.

Tease photo